University of California, Berkeley-Haas collection. The Napo Pharmaceuticals case scenario substantiates pupils with an example of a biotech company which has followed a triple bottom line of people, planet, and gain meanwhile making life saving drugs like crofelemer to take care of diarrhea in adult HIV/AIDS patients and potentially diarrhea for children and other neglected epidemics around the world. The case study centers on CEO and founder, Lisa Conte's challenging road to the stage where her supply associates and she achieved FDA approval for the drug. The case study outlines the issues such assignment-oriented biotech firms faced in the typical profit-oriented world of biotech.
Napo Pharmaceuticals Triple Bottom Line of People, Planet, and Profits (A) Case Study Solution
PUBLICATION DATE: February 14, 2014 PRODUCT #: B5784-PDF-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Gene Sequencing: Staking a Position in an Expanding Industry
YAAS’s Service Center (B)
Clear, Conspicuous, and Concise: Disclosures and Twitter Word-of-Mouth
Inundation: The Slow-Moving Crisis of Pakistan’s 2010 Floods (A)
Customer Co-Creation Projects and Social Media: The Case of Barilla of Italy
Navigating the Realm of the High-Potential Employee
Tailoring a Book Program for Managers: Why and How
Avid Radiopharmaceuticals: The Venture Debt Question
Baring Private Equity Partners India Limited: Banking Services for the Poor in Bangladesh
Please Stop Working So Hard!
